BEIJING, June 27 /Xinhua-PRNewswire/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced
in-vitro diagnostic products and high intensity focused ultrasound tumor therapy systems, today announced the filing of its annual report on Form 20-F for the fiscal year ended March 31, 2008 with the Securities and Exchange Commission. The annual report, which contains the Company’s audited consolidated financial statements, can be accessed on the Company’s investor relations website at http://ir.chinameditech.com .
Shareholders can receive a hard copy of the annual report free of charge by sending a request to IR@chinameditech.com.
About China Medical Technologies, Inc.
China Medical Technologies is a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products using Enhanced Chemiluminescence (ECLIA) technology and Fluorescent in situ Hybridization (FISH) technology, to detect and monitor various diseases and disorders, and products using High Intensity Focused Ultrasound (HIFU) for the treatment of solid cancers and benign tumors. For more information, please visit http://www.chinameditech.com .
